AI & ChatGPT searches , social queries for AGLEPRISTONE
Search references for AGLEPRISTONE. Phrases containing AGLEPRISTONE
See searches and references containing AGLEPRISTONE!
Search references for AGLEPRISTONE. Phrases containing AGLEPRISTONE
See searches and references containing AGLEPRISTONE!AGLEPRISTONE
Chemical compound
Aglepristone (INNTooltip International Nonproprietary Name) (brand name Alizin; former developmental code names RU-46534, RU-534) is a synthetic, steroidal
Aglepristone
Medical condition
return to normal values. If the procedure cannot be immediately performed aglepristone should be administered subcutaneously every 24 hours at a rate of 10 mg/kg
Hypersomatotropism (veterinary)
Hypersomatotropism_(veterinary)
Drug affecting hormone receptors
agonists (e.g., progesterone, progestins) and full antagonists (e.g., aglepristone) is that their action differs in different tissues, i.e. agonist in some
Selective progesterone receptor modulator
Selective_progesterone_receptor_modulator
Class of compounds
receptor modulator (SPRM) ulipristal acetate, and the silent antagonist aglepristone. In medical abortion, mifepristone is combined with a prostaglandin (e
Antiprogestogen
Corticosteroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Prednisolone
Steroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Prednisone
Drug class
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progestogen_ester
Injectable form of birth control
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Medroxyprogesterone_acetate
Steroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Triamcinolone
Gender-affirming medical treatment
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Gender-affirming hormone therapy
Gender-affirming_hormone_therapy
Class of steroid hormones
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Corticosteroid
Drug class
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progesterone synthesis inhibitor
Progesterone_synthesis_inhibitor
Medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Clobetasol_propionate
Type of corticosteroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Budesonide
Topics referred to by the same term
Alizin may refer to: Aglepristone, a drug Alizin, Iran, a village in Zanjan Province, Iran This disambiguation page lists articles associated with the
Alizin
Anabolic steroid
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Trenbolone
Combination drug
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Estradiol benzoate/progesterone/methandriol dipropionate
Estradiol_benzoate/progesterone/methandriol_dipropionate
Medicinal chemical compound, steroid
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Triamcinolone_acetonide
Steroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Betamethasone
Pharmaceutical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Pharmacology of cyproterone acetate
Pharmacology_of_cyproterone_acetate
Medication producing effects similar to progesterone
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progestogen_(medication)
Pharmaceutical birth control combination
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Ethinylestradiol/etonogestrel
Combination drug
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Estradiol valerate/cyproterone acetate
Estradiol_valerate/cyproterone_acetate
Antifungal chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Ketoconazole
Vertebrate natural glucocorticoid hormone
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Cortisol
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Trenbolone_enanthate
Type of steroid hormone
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Sex_hormone
Hormone therapy used to treat symptoms of menopause
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Hormone_replacement_therapy
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Methylprednisolone_succinate
Corticosteroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Methylprednisolone
Cytoplasmic receptor protein found inside cells
asoprisnil, asoprisnil ecamate) Antiprogestogens (e.g., mifepristone, aglepristone, onapristone, lonaprisan, lilopristone, toripristone) Progesterone receptor
Progesterone_receptor
Chemical compound
activity. List of investigational sex-hormonal agents § Progestogenics Aglepristone Lilopristone Onapristone Toripristone "Telapristone - Repros Therapeutics
Telapristone
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Cyproterone_acetate
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Fluticasone
Glucocorticoid steroid (chemical compound)
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Betamethasone_dipropionate
vilaprisan (BAY-1002670) Antiprogestogens (PR antagonists) Examples: aglepristone, onapristone (ZK-89299) Drugs that indirectly influence sex hormone systems
Sex-hormonal_agent
Anabolic–androgenic steroid
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Dimethyltrienolone
Chemical in plants
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Apigenin
Combination drug
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Nomegestrol_acetate/estradiol
Chemical compound
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Metribolone
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Triamcinolone_hexacetonide
Chemical compound
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Miconazole
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Tibolone
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Trenbolone_acetate
Medication drug
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Drospirenone
Progestin medication
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Norethisterone
Corticosteroid precursor and metabolite of cortisol
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Cortisone
Chemical compound
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Clogestone_acetate
Class of chemical compounds
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Hydrocortisone_butyrate
Glucocorticoid and mineralocorticoid hormone Cortisol supplied as a medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Hydrocortisone
Main sweet-tasting constituent of liquorice
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Glycyrrhizin
Synthetic and orally active anabolic–androgenic steroid (AAS)
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Tetrahydrogestrinone
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Methylprednisolone_aceponate
Hormonal medication used for birth control
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Levonorgestrel
Steroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Mometasone
Class of corticosteroids
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Glucocorticoid
Chemical compound
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Dexamethasone_acefurate
Steroid hormone that activates the progesterone receptor
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progestogen
Corticosteroid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Dexamethasone
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progestogen-only contraception
Progestogen-only_contraception
Combined oral contraceptive medication
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Mestranol/noretynodrel
Glucocorticoid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Fluticasone_propionate
Pharmaceutical combination
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Ethinylestradiol/levonorgestrel
Ethinylestradiol/levonorgestrel
Use of hormones in medical treatment
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Hormone_therapy
Antiprogestogen and antiglucocorticoid drug
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Mifepristone
Mineralocorticoid medication
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Fludrocortisone
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Proligestone
Medication used for epilepsy, bipolar disorder and migraine
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Valproate
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Hydroxyprogesterone heptanoate
Hydroxyprogesterone_heptanoate
Type of hormone replacement therapy with unclear efficacy
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Bioidentical hormone replacement therapy
Bioidentical_hormone_replacement_therapy
Antiandrogen medication
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Bicalutamide
Medication and naturally occurring steroid hormone
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progesterone_(medication)
Type of gender-affirming medical treatment
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Feminizing_hormone_therapy
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Clobetasol
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Paramethasone
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Fluocinonide
Sex hormone
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progesterone
Chemical compound
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Darolutamide
Chemical compound
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Diosgenin
Polycyclic organic compound having sterane as a core structure
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Steroid
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Desoximetasone
Chemical compound
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Tixocortol_pivalate
Medication
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Desogestrel
Chemical compound
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Melengestrol
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Ulipristal_acetate
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
17α-Hydroxyprogesterone
Type of contraceptive pill
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progestogen-only_pill
Intrauterine device
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Hormonal_intrauterine_device
Androgenic Anabolic steroid
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Nandrolone
Chemical compound
Fosdagrocorat Mapracorat Antagonists 7α-Hydroxy-DHEA 17α-Methylprogesterone Aglepristone Asoprisnil Asoprisnil ecamate C108297 C113176 CORT-108297 Cyproterone
Flugestone
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Osaterone_acetate
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Progestogen-only injectable contraceptive
Progestogen-only_injectable_contraceptive
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Delmadinone
Pharmaceutical drug
acetonide Triamcinolone acetonide esters Antiglucocorticoids Antagonists: Aglepristone Ketoconazole Mifepristone Ulipristal acetate Synthesis modifiers Acetoxolone
Deflazacort
Chemical compound
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Megestrol
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Mibolerone
Pharmaceutical drug classification
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
ATC_code_L02
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Trenbolone hexahydrobenzylcarbonate
Trenbolone_hexahydrobenzylcarbonate
Chemical compound
Telapristone§ Ulipristal acetate PRTooltip Progesterone receptor antagonists Aglepristone Mifepristone #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III
Nandrolone_cypionate
Steroidal antiandrogen and antimineralocorticoid
Kaempferol LG-120920 Naringenin PRA-910 Syringic acid Antagonists Steroidal: Aglepristone Lilopristone Lonaprisan Onapristone ORG-31710 ORG-31806 ORG-33628 RTI
Spironolactone
AGLEPRISTONE
AGLEPRISTONE
AGLEPRISTONE
AGLEPRISTONE
AGLEPRISTONE
AGLEPRISTONE
AGLEPRISTONE
AGLEPRISTONE
AGLEPRISTONE